[HTML][HTML] Appointment of Pfizer executive to CIHR stirs controversy
A Silversides - 2009 - Can Med Assoc
The appointment of a senior executive from pharmaceutical giant Pfizer Canada to the
governing council of the Canadian Institutes of Health Research (CIHR) has raised concern …
governing council of the Canadian Institutes of Health Research (CIHR) has raised concern …
Federal committee to review appointment of Pfizer vice-president to CIHR governing council
A Silversides - 2010 - Can Med Assoc
But Dr. Carolyn Bennett, Liberal MP for the Toronto, Ontario, riding of St Paul's and a
member of the health committee, said in an email that she was assured by governing council …
member of the health committee, said in an email that she was assured by governing council …
[HTML][HTML] Pharmaceutical industry representation on CIHR's governing council
Dr. Bernard Prigent, vice-president of medical affairs for Pfizer Canada, to the governing
council of the Canadian Institutes of Health Research (CIHR). He outlines a number of …
council of the Canadian Institutes of Health Research (CIHR). He outlines a number of …
[HTML][HTML] Tough on Crime? Pfizer and the CIHR
RG Evans - Healthcare Policy, 2010 - ncbi.nlm.nih.gov
The appointment of dr. Bernard Prigent, vice-president and medical director of Pfizer
Canada, to the Governing Council of the Canadian Institutes of Health Research, outraged …
Canada, to the Governing Council of the Canadian Institutes of Health Research, outraged …
[HTML][HTML] Doctors and drug companies—scrutinizing influential relationships
EG Campbell - New England Journal of Medicine, 2007 - Mass Medical Soc
On September 6, Senators Charles Grassley and Herb Kohl introduced the Physician
Payments Sunshine Act. Eric Campbell discusses the implications of the bill, which would …
Payments Sunshine Act. Eric Campbell discusses the implications of the bill, which would …
[HTML][HTML] Institutional financial conflicts of interest policies at Canadian academic health science centres: a national survey
Role of the sponsor: The funding organization did not participate in the design or conduct of
the study, in the collection, analysis, or interpretation of the data, or in the preparation …
the study, in the collection, analysis, or interpretation of the data, or in the preparation …
[HTML][HTML] Dances with the pharmaceutical industry
CMAJ• FEB. 19, 2002; 166 (4) 449 ing Director of the Joint Centre for Bioethics at the
University of Toronto, and Bartha Knoppers, an expert in health law and policy from …
University of Toronto, and Bartha Knoppers, an expert in health law and policy from …
Resignations at Canada's drug pricing panel raise independence questions
L Vogel - Canadian Medical Association. Journal, 2023 - search.proquest.com
A member of Canada's drug pricing regulator has resigned, stating the federal government
has undermined the independence and credibility of the organization. Dalhousie University …
has undermined the independence and credibility of the organization. Dalhousie University …
[HTML][HTML] Drug approval system questioned in US and Canada
L Eggertson - CMAJ, 2005 - Can Med Assoc
“There are serious problems in both the review function… and also in the postmarket
surveillance process.” Subsequent to Graham's testimony, a survey of almost 400 FDA …
surveillance process.” Subsequent to Graham's testimony, a survey of almost 400 FDA …
Report suggests NIH weigh consulting ban
J Kaiser - 2004 - science.org
A new report from the federal Office of Government Ethics (OGE) hints that the National
Institutes of Health (NIH) should consider a blanket ban on drug company consulting by …
Institutes of Health (NIH) should consider a blanket ban on drug company consulting by …
